Xtandi 80 MG tab 60S

Ended Awarded Last action

Contract number
SPE2DR26FBTVV
Awardee
Awarding agency
Obligated
$17,689

Award facts

Contract value 100% obligated
$17,688.64 Current and potential, with all options
Completion date
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6515 Medical And Surgical Instruments, Equipment, And Supplies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 18, 2026, for Xtandi 80 mg tablets with a ceiling value of $17,688.64.

The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceuticals and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, IL. The order is complete as of March 18, 2026.

Quick answers

Who was awarded contract SPE2DR26FBTVV?

SPE2DR26FBTVV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 18, 2026.

How much is contract SPE2DR26FBTVV worth?

The government has obligated $17,689 on SPE2DR26FBTVV.

Is contract SPE2DR26FBTVV an order under another contract?

Yes. SPE2DR26FBTVV is a delivery order under SPE2DR25D9628, an indefinite delivery contract.

Was contract SPE2DR26FBTVV competed?

The extent of competition for SPE2DR26FBTVV was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award